Xeris Biopharma Holdings (XERS) Operating Leases (2022 - 2026)
Xeris Biopharma Holdings' Operating Leases came in at $30.54 million for Q2 2026, down 5.9% from $32.44 million a year earlier and down 1.7% from the prior quarter.
Powered by 
Analysis
Xeris Biopharma Holdings (XERS) Operating Leases (2022 - 2026) Analysis & Trends
At the end of FY2025, Xeris Biopharma Holdings' Operating Leases was $31.53 million, down 5.2% from FY2024.
- Operating Leases carries a three-year compound annual growth rate of 49.7% (FY2022 to FY2025).
- Going back by year, Operating Leases was $33.26 million in FY2024 (-4.3%), $34.76 million in FY2023 (+269.8%) and $9.4 million in FY2022.
- The Q2 2026 figure represents the lowest quarterly Operating Leases since Q1 2023.
- Year-over-year, Operating Leases has declined for nine consecutive quarters, with an average decline of 4.9% over the last eight quarters.
- The fastest year-over-year change in Operating Leases over five years came in Q4 2023 (growth of 269.8%), and the weakest in Q2 2026 (a decline of 5.9%).
- Business Quant data shows XERS's Operating Leases at $31.06 million (Q1 2026), $31.53 million (Q4 2025) and $31.99 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Xeris Biopharma Holdings | 1.71 Bn | 1.27 Bn | 79.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.54 Mn |
| Mar 31, 2026 | 31.06 Mn |
| Dec 31, 2025 | 31.53 Mn |
| Sep 30, 2025 | 31.99 Mn |
| Jun 30, 2025 | 32.44 Mn |
| Mar 31, 2025 | 32.87 Mn |
| Dec 31, 2024 | 33.26 Mn |
| Sep 30, 2024 | 33.64 Mn |
| Jun 30, 2024 | 34.02 Mn |
| Mar 31, 2024 | 34.40 Mn |
| Dec 31, 2023 | 34.76 Mn |
| Sep 30, 2023 | 35.15 Mn |
| Jun 30, 2023 | 34.87 Mn |
| Mar 31, 2023 | 9.35 Mn |
| Dec 31, 2022 | 9.40 Mn |
API Access
Xeris Biopharma Holdings Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=XERS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "XERS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=XERS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();